scorecardresearch
Add as a preferred source on Google
Sunday, April 5, 2026
HomeHealth

Health

Not just cigarettes, Australian study finds vaping can cause cancer too

“Vapes were introduced 20 years ago. We shouldn’t wait 80 more years to decide what to do,” one author of the study said.

Drug regulator calls on Indian pharma to move beyond generics, address dependence on bulk imports

Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.

MIT study answers why some cancer treatments fail. Most tumours have active backdoor pathways

Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.

In a small town in Gujarat, researchers are training AI to detect anaemia, without drawing blood

Innovation one of 33 shortlisted from over 150 applications got under ICMR-NIN INFUSE initiative. Study protocol published preprint last April, intended product is a smartphone app.

A 5-spice mix to fight long-term diabetes & obesity complications? ICMR set to back human trials

Looking beyond blood sugar control, ICMR-NIN scientists have combined 5 regular kitchen spices in precise proportions, 'marking a shift toward integrative health solutions'.

As GLP-1 generics flood Indian market, drug regulator cracks down on illegal sale & misleading ads

The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.

NEET-PG cut-off reduction didn’t alter merit, only expanded pool—Centre reiterates stand in SC

The affidavit is the government's third submission to the SC in response to a writ petition filed by social worker Harisharan Devgan & others challenging the January cut-off revision.

‘Price no challenge, mindset is’: Novo Nordisk eyes next-gen anti-obesity drugs as generics enter market

Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.

Yes or no to front-of-pack warning labels? Industry, consumer groups dig their heels in at FSSAI meet

Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.

Why do women make up two-thirds of Alzheimer’s cases? Study links risk to hormonal changes in midlife

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.

On Camera

US pilot rescue in Iran must be seen more than war cost. Nation protects its warriors

A live American pilot paraded on Iranian state television would have been an intelligence windfall and a propaganda coup of historic proportions.

What to expect from China’s new 5-year plan—trade innovation, tensions with partners

ASEAN is struggling against a flood of 'underpriced Chinese goods', while Brazil has imposed anti-dumping duties on Chinese steel.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.